Thanks to the various blogs (BrandWeekNrx, PharmaGossip, PharmaLot, PharmaBlogosphere, and others) that reported on this blog’s inaugural posts. To clarify, the name of the blog is not “Ask Pharmie.”

Ask Pharmie is a feature that will appear from time to time on the blog, answering readers’ questions about the pharmaceutical industry and its pricing and marketing tactics. The name of the blog is, compared to the luminaries of the Pharma Blogosphere, quite plain: simply, The Prescription Access Litigation Blog.